MTOR and diabetic kidney disease: Recent studies also indicate the importance of the mTOR signaling pathway in podocytes in the progression of glomerular disease, so the use of mTOR inhibitors in immunosuppressive therapy may have a potential role in the prevention of diabetic nephropathy [37,104,105].